Department of Justice 2013 – Federal Register Recent Federal Regulation Documents

Results 751 - 800 of 800
Manufacturer of Controlled Substances; Notice of Registration; Noramco, Inc.
Document Number: 2013-01600
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration; Morton Grove Pharmaceuticals
Document Number: 2013-01592
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Application; Siegfried (USA)
Document Number: 2013-01591
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances, Notice of Registration; Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2013-01588
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application; Cerilliant Corporation
Document Number: 2013-01556
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; R & D Systems, Inc.
Document Number: 2013-01554
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances, Notice of Registration, Myoderm
Document Number: 2013-01540
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2013-01536
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Chemic Laboratories, Inc.
Document Number: 2013-01535
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Ampac Fine Chemicals, LLC
Document Number: 2013-01534
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration; Cerilliant Corporation
Document Number: 2013-01533
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Fisher Clinical Services, Inc.
Document Number: 2013-01532
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Registration; Chattem Chemicals, Inc.
Document Number: 2013-01530
Type: Notice
Date: 2013-01-25
Agency: Drug Enforcement Administration, Department of Justice
Exempt Chemical Preparations Under the Controlled Substances Act
Document Number: 2013-01133
Type: Notice
Date: 2013-01-22
Agency: Drug Enforcement Administration, Department of Justice
The applications for exempt chemical preparations received by DEA between June 12, 2011, and June 30, 2012, as listed below, were accepted for filing and have been approved or denied as indicated.
United States
Document Number: 2013-01084
Type: Notice
Date: 2013-01-22
Agency: Antitrust Division, Department of Justice
Sunshine Act Meeting
Document Number: 2013-00953
Type: Notice
Date: 2013-01-16
Agency: Foreign Claims Settlement Commission, Department of Justice
Solicitation for a Cooperative Agreement: Development of Materials Specific to Lesbian, Gay, Bisexual, Transgender and Intersex (LGBTI) Offenders in Corrections
Document Number: 2013-00846
Type: Notice
Date: 2013-01-16
Agency: Department of Justice, National Institute of Corrections
The National Institute of Corrections (NIC) is seeking applications from organizations, groups, or individuals to enter into a cooperative agreement with NIC for a 12-month period to develop a white paper specific to recommended best practices in the safe and respectful management of the LGBTI offender population both in custody and on community supervision.
Criminal Justice Interview Room Recording System (IRRS) Standard, Supplier's Declaration of Conformity Requirements, and Selection and Application Guide
Document Number: 2013-00464
Type: Notice
Date: 2013-01-11
Agency: Department of Justice, Office of Justice Programs
In an effort to obtain comments from interested parties, the U.S. Department of Justice, Office of Justice Programs, National Institute of Justice (NIJ) will make available to the general public three draft documents related to Interview Room Recording Systems (IRRS) used by criminal justice agencies: 1. Draft Criminal Justice IRRS Standard 2. Draft Criminal Justice IRRS Supplier's Declaration of Conformity Requirements 3. Draft Criminal Justice IRRS Selection and Application Guide The opportunity to provide comments on these documents is open to industry technical representatives; criminal justice agencies and organizations; research, development, and scientific communities; and all other stakeholders and interested parties. Those individuals wishing to obtain and provide comments on the draft documents under consideration are directed to the following Web site: https:// www.justnet.org.
Agency Information Collection Activities: Proposed Collection; Comments Requested; Appeals of Background Checks
Document Number: 2013-00394
Type: Notice
Date: 2013-01-11
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Agency Information Collection Activities: Proposed Collection; Comments Requested, Application for Federal Firearms License
Document Number: 2013-00392
Type: Notice
Date: 2013-01-11
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
Notice of Lodging Proposed Consent Decree
Document Number: 2013-00284
Type: Notice
Date: 2013-01-10
Agency: Department of Justice
Sunshine Act Meeting
Document Number: 2013-00112
Type: Notice
Date: 2013-01-07
Agency: Department of Justice, Parole Commission
Establishment of Drug Codes for 26 Substances
Document Number: 2012-31698
Type: Rule
Date: 2013-01-04
Agency: Drug Enforcement Administration, Department of Justice
On July 9, 2012, the President signed into law the Synthetic Drug Abuse Prevention Act of 2012 (SDAPA). SDAPA amends the Controlled Substances Act by placing 26 substances in Schedule I. DEA is publishing this rule to establish drug codes for these 26 substances, and to make technical and conforming amendments in accordance with SDAPA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.